Search details
1.
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis.
J Hepatol
; 80(1): 62-72, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37865273
2.
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
Gut
; 73(1): 156-165, 2023 Dec 07.
Article
in English
| MEDLINE | ID: mdl-37884354
3.
Assessment of glomerular filtration rate in patients with cirrhosis: Available tools and perspectives.
Liver Int
; 42(11): 2360-2376, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35182100
4.
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium.
J Hepatol
; 74(1): 200-219, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32896580
5.
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
J Hepatol
; 72(4): 688-701, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31778751
6.
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis.
Clin Gastroenterol Hepatol
; 18(4): 963-973.e14, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31394283
7.
Reply to: "The impact of infections on the onset of contrast-associated acute kidney injury in patients with cirrhosis".
J Hepatol
; 80(5): e227-e228, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38307345
8.
HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms.
J Pediatr Gastroenterol Nutr
; 69(1): 39-44, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31232884
9.
Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701].
J Hepatol
; 72(6): 1218-1220, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32192825
10.
Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.
Liver Int
; 35(8): 2027-35, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25495478
11.
Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function.
Dig Liver Dis
; 54(8): 1101-1108, 2022 08.
Article
in English
| MEDLINE | ID: mdl-34625366
12.
Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy.
Curr Oncol
; 29(3): 1422-1429, 2022 02 24.
Article
in English
| MEDLINE | ID: mdl-35323319
13.
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
Hepatol Commun
; 6(5): 1100-1112, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34964311
14.
Liver involvement in adult-onset Still's disease: our experience in a third level liver unit and review of the literature.
Minerva Gastroenterol (Torino)
; 2021 May 12.
Article
in English
| MEDLINE | ID: mdl-33978390
15.
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Gastroenterol Hepatol
; 5(1): 31-41, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31607677
16.
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.
World J Hepatol
; 11(6): 489-512, 2019 Jun 27.
Article
in English
| MEDLINE | ID: mdl-31293718
17.
The role of microbiota in autism spectrum disorders.
Minerva Gastroenterol Dietol
; 64(4): 333-350, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-29600698
18.
Gastrointestinal tract disorders in the elderly.
Minerva Med
; 108(6): 575-591, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28974085
19.
Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
Med Oncol
; 33(10): 104, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27566310
Results
1 -
19
de 19
1
Next >
>>